The first human trials of a revolutionary cancer vaccine that could save thousands of lives a year is set to begin, according to scientists in Britain.
The immune-boosting leukemia jab will be tried out on volunteers who have either chronic or acute myeloid leukemia - two forms of bone marrow and blood cancer.
If successful, the DNA vaccine, developed at Southampton University, could be available in five years, reports the Daily Express.
"We're very excited. This vaccine has real promise," the Leukemia and Lymphoma Research charity said.